nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP9—periosteum—cleft lip	0.0765	0.163	CbGeAlD
Captopril—MMP2—cartilage tissue—cleft lip	0.0617	0.131	CbGeAlD
Captopril—MMP9—cartilage tissue—cleft lip	0.0536	0.114	CbGeAlD
Captopril—LTA4H—mouth—cleft lip	0.0353	0.0752	CbGeAlD
Captopril—MMP2—EPH-ephrin mediated repulsion of cells—EPHA3—cleft lip	0.0277	0.0523	CbGpPWpGaD
Captopril—REN—mouth—cleft lip	0.0272	0.058	CbGeAlD
Captopril—LTA4H—embryo—cleft lip	0.0252	0.0536	CbGeAlD
Captopril—MMP2—mouth—cleft lip	0.025	0.0533	CbGeAlD
Captopril—MMP9—mouth—cleft lip	0.0218	0.0464	CbGeAlD
Captopril—REN—ACE Inhibitor Pathway—NOS3—cleft lip	0.0214	0.0403	CbGpPWpGaD
Captopril—LTA4H—telencephalon—cleft lip	0.0205	0.0436	CbGeAlD
Captopril—F2—Folate Metabolism—MTHFS—cleft lip	0.019	0.0357	CbGpPWpGaD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—EPHA3—cleft lip	0.0182	0.0343	CbGpPWpGaD
Captopril—MMP2—embryo—cleft lip	0.0179	0.038	CbGeAlD
Captopril—MMP2—EPH-Ephrin signaling—EPHA3—cleft lip	0.0162	0.0305	CbGpPWpGaD
Captopril—MMP9—embryo—cleft lip	0.0155	0.0331	CbGeAlD
Captopril—MMP2—FOXM1 transcription factor network—TGFA—cleft lip	0.0144	0.0271	CbGpPWpGaD
Captopril—LTA4H—head—cleft lip	0.0127	0.0271	CbGeAlD
Captopril—ACE—mouth—cleft lip	0.0116	0.0247	CbGeAlD
Captopril—MMP9—EPH-Ephrin signaling—EPHA3—cleft lip	0.0106	0.02	CbGpPWpGaD
Captopril—REN—head—cleft lip	0.00983	0.0209	CbGeAlD
Captopril—ACE—ACE Inhibitor Pathway—NOS3—cleft lip	0.00954	0.018	CbGpPWpGaD
Captopril—MMP2—head—cleft lip	0.00904	0.0193	CbGeAlD
Captopril—F2—Vitamin B12 Metabolism—TCN2—cleft lip	0.00862	0.0163	CbGpPWpGaD
Captopril—F2—Folate Metabolism—SLC19A1—cleft lip	0.00847	0.016	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—SPRY2—cleft lip	0.0083	0.0156	CbGpPWpGaD
Captopril—ACE—embryo—cleft lip	0.00827	0.0176	CbGeAlD
Captopril—MMP9—Angiogenesis—FGFR2—cleft lip	0.00787	0.0148	CbGpPWpGaD
Captopril—MMP9—head—cleft lip	0.00786	0.0167	CbGeAlD
Captopril—MMP2—Syndecan-2-mediated signaling events—FGFR3—cleft lip	0.00764	0.0144	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—BHMT2—cleft lip	0.00753	0.0142	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—MTHFS—cleft lip	0.00752	0.0142	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—NANS—cleft lip	0.00749	0.0141	CbGpPWpGaD
Captopril—F2—head—cleft lip	0.00686	0.0146	CbGeAlD
Captopril—ACE—telencephalon—cleft lip	0.00673	0.0143	CbGeAlD
Captopril—MMP2—Direct p53 effectors—TP63—cleft lip	0.00653	0.0123	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EPHA3—cleft lip	0.00602	0.0113	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—PTCH1—cleft lip	0.006	0.0113	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—MTR—cleft lip	0.00598	0.0113	CbGpPWpGaD
Captopril—MMP9—Syndecan-4-mediated signaling events—FGFR1—cleft lip	0.00583	0.011	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—cleft lip	0.0057	0.0107	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB3—cleft lip	0.00567	0.0107	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TGFA—cleft lip	0.00549	0.0103	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—FGF2—cleft lip	0.00536	0.0101	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—NOS3—cleft lip	0.00528	0.00996	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—NOS3—cleft lip	0.00525	0.00989	CbGpPWpGaD
Captopril—ABCB1—ABC-family proteins mediated transport—ABCA4—cleft lip	0.00523	0.00985	CbGpPWpGaD
Captopril—F2—Folate Metabolism—MTR—cleft lip	0.00486	0.00916	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—FGFR3—cleft lip	0.0048	0.00905	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—FGF2—cleft lip	0.00454	0.00856	CbGpPWpGaD
Captopril—F2—Syndecan-4-mediated signaling events—FGFR1—cleft lip	0.0045	0.00848	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—NOS3—cleft lip	0.00448	0.00844	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EPHA3—cleft lip	0.00429	0.0081	CbGpPWpGaD
Captopril—MMP9—Syndecan-4-mediated signaling events—FGF2—cleft lip	0.00426	0.00802	CbGpPWpGaD
Captopril—ACE—head—cleft lip	0.00419	0.00893	CbGeAlD
Captopril—MMP9—FGF signaling pathway—FGFR2—cleft lip	0.00411	0.00775	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—NANS—cleft lip	0.00397	0.00748	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EPHA3—cleft lip	0.00395	0.00744	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—MTR—cleft lip	0.00386	0.00728	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGF7—cleft lip	0.00385	0.00726	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—FGFR1—cleft lip	0.00383	0.00723	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—cleft lip	0.00374	0.00704	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—NANS—cleft lip	0.00372	0.00701	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB3—cleft lip	0.00372	0.00701	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—SUMO1—cleft lip	0.00366	0.00689	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—FGFR3—cleft lip	0.00362	0.00683	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—NOS3—cleft lip	0.00359	0.00676	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGF8—cleft lip	0.00355	0.0067	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—NOS3—cleft lip	0.00344	0.00649	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TCN2—cleft lip	0.00342	0.00645	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—MYC—cleft lip	0.00341	0.00643	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SLC19A1—cleft lip	0.00336	0.00633	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—FGFR1—cleft lip	0.00335	0.00631	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—NANS—cleft lip	0.00334	0.0063	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.00331	0.00624	CbGpPWpGaD
Captopril—CYP2D6—telencephalon—cleft lip	0.00329	0.00701	CbGeAlD
Captopril—F2—Syndecan-4-mediated signaling events—FGF2—cleft lip	0.00329	0.00619	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SLC19A1—cleft lip	0.00323	0.00608	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—MTHFR—cleft lip	0.0032	0.00603	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—BMP4—cleft lip	0.00317	0.00597	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—FGFR3—cleft lip	0.00316	0.00596	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB3—cleft lip	0.00296	0.00558	CbGpPWpGaD
Captopril—ABCB1—embryo—cleft lip	0.00291	0.0062	CbGeAlD
Captopril—MMP9—Signaling by SCF-KIT—FGF3—cleft lip	0.00289	0.00545	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF7—cleft lip	0.00284	0.00536	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB3—cleft lip	0.00282	0.00532	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGF9—cleft lip	0.00282	0.00531	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EPHA3—cleft lip	0.00282	0.00531	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NODAL—cleft lip	0.00277	0.00522	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TCN2—cleft lip	0.00267	0.00504	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF8—cleft lip	0.00262	0.00495	CbGpPWpGaD
Captopril—F2—Folate Metabolism—MTHFR—cleft lip	0.0026	0.00491	CbGpPWpGaD
Captopril—F2—PAR1-mediated thrombin signaling events—NOS3—cleft lip	0.00256	0.00482	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—FGF2—cleft lip	0.00244	0.00461	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGF10—cleft lip	0.00238	0.00448	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—MTR—cleft lip	0.00237	0.00447	CbGpPWpGaD
Captopril—ABCB1—telencephalon—cleft lip	0.00237	0.00505	CbGeAlD
Captopril—MMP9—AGE/RAGE pathway—NOS3—cleft lip	0.00235	0.00443	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—FGF2—cleft lip	0.0023	0.00433	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—WNT9B—cleft lip	0.00228	0.00429	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—cleft lip	0.00227	0.00427	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF3—cleft lip	0.00214	0.00403	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF9—cleft lip	0.00208	0.00393	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—BMP4—cleft lip	0.00208	0.00392	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—MTHFR—cleft lip	0.00207	0.0039	CbGpPWpGaD
Captopril—CYP2D6—head—cleft lip	0.00205	0.00437	CbGeAlD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—cleft lip	0.00204	0.00384	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—SUMO1—cleft lip	0.00194	0.00365	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—MTR—cleft lip	0.00193	0.00364	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGFR2—cleft lip	0.00191	0.0036	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—NANS—cleft lip	0.00188	0.00355	CbGpPWpGaD
Captopril—LTA4H—Metabolism—MTR—cleft lip	0.00185	0.00349	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—SUMO1—cleft lip	0.00182	0.00342	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NODAL—cleft lip	0.00182	0.00342	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—WNT3—cleft lip	0.00181	0.00341	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGFR1—cleft lip	0.00178	0.00335	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF10—cleft lip	0.00176	0.00331	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB3—cleft lip	0.00171	0.00322	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGFR3—cleft lip	0.00168	0.00317	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—SUMO1—cleft lip	0.00163	0.00308	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ARHGAP29—cleft lip	0.00163	0.00307	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00162	0.00304	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—MTR—cleft lip	0.00153	0.00289	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—MYC—cleft lip	0.00149	0.0028	CbGpPWpGaD
Captopril—ABCB1—head—cleft lip	0.00148	0.00314	CbGeAlD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR2—cleft lip	0.00141	0.00266	CbGpPWpGaD
Captopril—MMP2—Axon guidance—FGFR1—cleft lip	0.00139	0.00263	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—MYC—cleft lip	0.00135	0.00254	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—cleft lip	0.00134	0.00252	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—FGF10—cleft lip	0.00133	0.00251	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR1—cleft lip	0.00131	0.00248	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.00131	0.00248	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGF2—cleft lip	0.0013	0.00245	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—MTHFR—cleft lip	0.00127	0.00239	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ARHGAP29—cleft lip	0.00126	0.00237	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR3—cleft lip	0.00124	0.00234	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—FGF2—cleft lip	0.0012	0.00226	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCA4—cleft lip	0.0012	0.00226	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—WNT9B—cleft lip	0.00117	0.0022	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TYMS—cleft lip	0.00114	0.00214	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00104	0.00196	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—MTHFR—cleft lip	0.00103	0.00195	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—FGFR1—cleft lip	0.000995	0.00187	CbGpPWpGaD
Captopril—LTA4H—Metabolism—MTHFR—cleft lip	0.000993	0.00187	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—PTCH1—cleft lip	0.000991	0.00187	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—MYC—cleft lip	0.000979	0.00185	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGF2—cleft lip	0.00096	0.00181	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—WNT3—cleft lip	0.000928	0.00175	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—SUMO1—cleft lip	0.00092	0.00173	CbGpPWpGaD
Captopril—MMP9—Axon guidance—FGFR1—cleft lip	0.000914	0.00172	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—WNT9B—cleft lip	0.000894	0.00168	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—FGF10—cleft lip	0.000872	0.00164	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOG—cleft lip	0.000857	0.00162	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	0.000821	0.00155	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ABCA4—cleft lip	0.000797	0.0015	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—FGF2—cleft lip	0.000787	0.00148	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—MTR—cleft lip	0.00074	0.0014	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—FGF2—cleft lip	0.000726	0.00137	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—WNT3—cleft lip	0.00071	0.00134	CbGpPWpGaD
Captopril—LTA4H—Metabolism—NOS3—cleft lip	0.000692	0.0013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WNT9B—cleft lip	0.00069	0.0013	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB3—cleft lip	0.000677	0.00128	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOG—cleft lip	0.000662	0.00125	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—FGFR1—cleft lip	0.000652	0.00123	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000623	0.00117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ABCA4—cleft lip	0.000615	0.00116	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WNT3—cleft lip	0.000548	0.00103	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000546	0.00103	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.000531	0.001	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTCH1—cleft lip	0.000508	0.000958	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—FGF2—cleft lip	0.000476	0.000898	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF7—cleft lip	0.00047	0.000885	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPRY2—cleft lip	0.00047	0.000885	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000443	0.000835	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF8—cleft lip	0.000433	0.000817	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTCH1—cleft lip	0.000389	0.000733	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000375	0.000706	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPRY2—cleft lip	0.000363	0.000683	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF7—cleft lip	0.000363	0.000683	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS3—cleft lip	0.000356	0.000671	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF3—cleft lip	0.000353	0.000665	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF9—cleft lip	0.000344	0.000648	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF8—cleft lip	0.000335	0.000631	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTCH1—cleft lip	0.0003	0.000566	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF10—cleft lip	0.00029	0.000547	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000274	0.000516	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF3—cleft lip	0.000272	0.000513	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC19A1—cleft lip	0.000267	0.000503	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF9—cleft lip	0.000266	0.000501	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC19A1—cleft lip	0.000234	0.000441	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR2—cleft lip	0.000233	0.000439	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF10—cleft lip	0.000224	0.000422	CbGpPWpGaD
Captopril—ALB—Metabolism—TCN2—cleft lip	0.000221	0.000417	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC19A1—cleft lip	0.00022	0.000415	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR1—cleft lip	0.000217	0.000409	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR3—cleft lip	0.000205	0.000387	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TCN2—cleft lip	0.000194	0.000365	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TCN2—cleft lip	0.000183	0.000344	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR2—cleft lip	0.00018	0.000339	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000179	0.000337	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR1—cleft lip	0.000168	0.000316	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF2—cleft lip	0.000158	0.000299	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR3—cleft lip	0.000158	0.000298	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—cleft lip	0.000156	0.000295	CbGpPWpGaD
Captopril—ALB—Metabolism—MTR—cleft lip	0.000153	0.000289	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—cleft lip	0.000141	0.000266	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTR—cleft lip	0.000134	0.000253	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTR—cleft lip	0.000127	0.000239	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF2—cleft lip	0.000122	0.000231	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—cleft lip	0.000121	0.000227	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—cleft lip	0.000104	0.000195	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMS—cleft lip	9.4e-05	0.000177	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMS—cleft lip	8.23e-05	0.000155	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—cleft lip	8.21e-05	0.000155	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—cleft lip	8e-05	0.000151	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMS—cleft lip	7.76e-05	0.000146	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—cleft lip	7.19e-05	0.000136	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—cleft lip	6.78e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—cleft lip	5.73e-05	0.000108	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—cleft lip	5.02e-05	9.46e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—cleft lip	4.73e-05	8.91e-05	CbGpPWpGaD
